Johnson & Johnson has paused…
Johnson & Johnson has paused further enrollment in a phase [...]
Sanofi has backed the $75 million…
Sanofi has backed the $75 million series B of a [...]
In a deal with Theriva Biologics…
In a deal with Theriva Biologics potentially worth as much [...]
Only a couple of months ago,…
Only a couple of months ago, Sensei Biotherapeutics was laying [...]
Unnatural Products is proving to…
Unnatural Products is proving to be a natural at securing [...]
Boehringer Ingelheim is discarding…
Boehringer Ingelheim is discarding an inhaled gene therapy designed to [...]
Japan-based cell therapy company…
Japan-based cell therapy company Innovacell is planning to end a [...]
Cyrano Therapeutics is savoring a…
Cyrano Therapeutics is savoring a phase 2 victory. With the [...]
The FDA has rejected a rare blood…
The FDA has rejected a rare blood disease candidate from [...]
Just as a disciplined soccer…
Just as a disciplined soccer player might pass on a [...]